Can CD147 work as a therapeutic target for tumors through COVID-19 infection?

In this review, we discussed an interesting case infected with “COVID-19” (Corona Virus Disease 2019). The patients with Hodgkin's lymphoma recovered after infection with COVID-19. It may be that COVID-19 activates the patient's immune system, or it may be a coincidence. COVID-19 spike pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Hao-Lin, Wen, Gui-Min, Zhao, Zhen-Ying, Liu, Da-Hua, Xia, Pu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724241/
https://www.ncbi.nlm.nih.gov/pubmed/36483594
http://dx.doi.org/10.7150/ijms.79162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724241/
https://www.ncbi.nlm.nih.gov/pubmed/36483594
http://dx.doi.org/10.7150/ijms.79162

Ejemplares similares